ArticleInternational journal of clinical pharmacy2012
Impact of community pharmaceutical care on patient health and quality of drug treatment in Parkinson's disease.
Article in International journal of clinical pharmacy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Health-related quality of life in Parkinson's disease: systematic review and meta-analysis of EuroQol (EQ-5D) utility scores.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024Pooled it
- Interventions to improve the appropriate use of polypharmacy for older people.The Cochrane database of systematic reviews · 2018Pooled it
- Assessment of the construct validity and responsiveness of preference-based quality of life measures in people with Parkinson's: a systematic review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2017Pooled it
- Impact of pharmacist-physician collaboration on patient outcomes in Parkinson's disease: a randomised controlled trial in tertiary care.International journal of clinical pharmacy · 2025Trial
- Systematic literature review of the impact of psychiatric pharmacists.The mental health clinician · 2024Review
- The Impact of Pharmacist-Led Medication Management Services on the Quality of Life and Adverse Drug Reaction Occurrence.Pharmacy (Basel, Switzerland) · 2022Article
- A qualitative exploration of the healthcare challenges and pharmaceutical care needs of people with Parkinson's and their caregivers.International journal of clinical pharmacy · 2022Article
- Moving towards Integrated and Personalized Care in Parkinson's Disease: A Framework Proposal for Training Parkinson Nurses.Journal of personalized medicine · 2021Review
- Enhancing medication therapy in Parkinson's disease by establishing an interprofessional network including pharmacists.International journal of clinical pharmacy · 2021Article
- Happiness: A Novel Outcome in Parkinson Studies?Journal of Parkinson's disease · 2020Article
- Advances in clinical pharmacy education in Germany: a quasi-experimental single-blinded study to evaluate a patient-centred clinical pharmacy course in psychiatry.BMC medical education · 2017Article
- Impact of medication therapy management in patients with Parkinson's disease.International journal of clinical pharmacy · 2016Article
- Practice recommendations for Parkinson's disease: Assessment and management by community pharmacists.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC · 2015Article
- Enhanced medication management services in the community: A win-win proposal from an economic, clinical and humanistic perspective.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe well-being of patients with Parkinson's disease may be improved by pharmaceutical care in community pharmacies.
objectiveTo investigate the effects of standardised pharmaceutical care on health outcomes and quality of drug treatment in patients with Parkinson's disease.
settingCommunity pharmacies in Germany.
methodAn open-label, multicentre, longitudinal, parallel-group study was conducted in outpatients with idiopathic Parkinson's disease who were receiving anti-parkinsonian medication. Patients were recruited by 32 community pharmacists (pharmacy group) and local offices of the German Parkinson's disease patients' association (comparison group). All patients were assessed at baseline and at 8 months' follow-up. In the intervening period, the pharmacists provided patients in the pharmacy group with standardised pharmaceutical care.
main outcome measureMean change in symptom-related impairment of health status, assessed using the 23-item Parkinson's Scale Total Score.
resultsIn total 235 patients were enrolled into the study (113 pharmacy group; 122 comparison group). Between-group analysis showed that the mean changes in the primary and secondary endpoints, all 23-item Parkinson's Scale sub-scores and the EuroQol 5-Dimension Questionnaire Index Score were significantly in favour of the pharmacy group after 8 months (p < 0.05 to p < 0.001), using a mixed model analysis. No significant changes were observed in prescribers' guideline adherence, but there was a significant decrease in the proportion of patients receiving inappropriate drugs according to the Beers List in the pharmacy group (p < 0.01).
conclusionThis study shows that significant benefits in patient health outcomes and age-related quality of drug treatment were gained when patients with Parkinson's disease were provided with standardised pharmaceutical care in community pharmacies.
Indexed as
Identifiers
22810890What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.